Ferritin Quantitative Test

COVID-19 Ag & Flu A/B Combo Self Test

COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B.

Product Detail

Introduction

Multiple viral infections is a trend, and many COVID-19 patients have multiple viral infections. Coinfection in COVID-19 patients may worsen disease outcomes. We found that a higher proportion of patients with COVID-19 were coinfected with one or more additional pathogens. [ From JCLA Journal of Clinical Laboratory Analysis ]

Symptoms caused by the infection of SARS-CoV-2 and Influenza viruses are very similar, which brings a huge challenge in diagnosis and timely medical treatment. Biotime Flu A/B & COVID-19 Ag Combo Test with differentiated detection of the multiple pathogens will reduce times and uncertainty on the initial screening of patients with SARS-CoV-2 or Influenza.

 

Product Features

Rapid : Results in 15 mins

Non-invasive diagnosis : Nasal swab sample

Robust : All-in-one package for POC testing

Efficiency : Rapidly differentiate 3 infections in 1 test

Easy & Convenient : Easy operation and no need for extra equipment

Transportation & Stroage : No need refrigerated transportation and store at room temperature

 

Product specification

Product Name

COVID-19 Ag & Flu A/B Combo Self Test

Sample Type 

Nasal swab

Loading Volume 

65uL

Reaction Time

15 mins

Shelf Life

18 months

Storage Condition

2-30℃

Unit

20 kits/box

 


Test Procedure 

1. Carefully peel off the sealing film on the tube to avoid spilling any fluid. Place sealing film in the plastic waste bag provided.

2. Place the extraction tube in the extraction tube holder (attached inside the box) to avoid spilling the liquid.

3. Open the swab packaging and take out the swab.

4. Insert the swab into both nostrils 5 times about 2.5 cm (1 inch).

5. Withdraw the swab from the nasal cavity, rotating the swab for about 10 seconds to release the antigen into the extraction solution from the swab head.

6. Install the nozzle cap onto the extraction tube.

7. Loading: drip 2 drops (about 65μL) of extraction solution into the left sample well  of the test cartridge.

    Loading: drip 2 drops (about 65μL) of extraction solution into the right sample well of the test cartridge, and start the timer, read the results at 15 minutes.



Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
S100-β Rapid Quantitative Test (Fluorescence Immunoassay)
S100-β Rapid Quantitative Test (Fluorescence Immunoassay)
The Biotime S100-β Rapid Quantitative Test is intended to quantify the concentration of S100-β in human serum, plasma, and whole blood on the Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid in the detection of neurological injury.
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)
HBP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Heparin binding protein (HBP) concentration in human plasma that contains Sodium Citrate samples, mainly used for auxiliary diagnosis of inflammation diseases.
Biotime LH Rapid Quantitative Test
LH Rapid Quantitative Test
Luteinizing hormone is a hormone produced by gonadotropic cells in the anterior pituitary gland. In females, an acute rise of LH ("LH surge") triggers ovulation and development of the corpus luteum. In males, where LH had also been called interstitial cell‒stimulating hormone (ICSH), it stimulates Leydig cell production of testosterone. It acts synergistically with follicle-stimulating hormone (FSH).
FIA Analyzer
FLI-100 FIA Analyzer
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
Biotime SAA Rapid Quantitative Test
SAA Rapid Quantitative Test
Serum amyloid A (SAA) is a major acute phase protein in human beings, and dogs. The level of SAA proteins in blood increases within just a few hours following the onset of various inflammatory stimuli. These include infection, trauma and surgery
FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay)
FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay)
FT3 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free triiodothyronine 3 (FT3) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
Toxoplasma IgG/IgM Rapid Test (Fluorescence Immunoassay)
Toxoplasma IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheToxoplasma IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toToxoplasma gondii in human serum.IgG results with this assay are used to indicate past or recent infection withToxoplasma gondii. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recentToxoplasma gondii infections. Toxoplasma IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Toxoplasma gondii infection -For in vitro diagnostic use only. For professional use only.
CMV IgG/IgM Rapid Test (Fluorescence Immunoassay)
CMV IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheCMV IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toCMV in human serum. IgG results with this assay are used to indicate past or recent infection with CMV. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent CMV infections. CMV IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Cytomegalovirus (CMV) infection -For in vitro diagnostic use only. For professional use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact